Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.

@article{Binderup2008QuantitativeGE,
  title={Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.},
  author={Tina Binderup and Ulrich Knigge and Anne Mellon Mogensen and Carsten Palnaes Hansen and Andreas Kjaer},
  journal={Neuroendocrinology},
  year={2008},
  volume={87 4},
  pages={223-32}
}
AIM To measure, by a quantitative approach, the gene expression underlying the results of somatostatin receptor (sst) scintigraphy ((111)In-DTPA-octreotide) and noradrenaline transporter (NAT) scintigraphy ((123)I-MIBG) in patients with neuroendocrine (NE) tumors. METHODS The gene expression of somatostatin receptors 1-5 (sst) and NAT was measured quantitatively by real-time PCR in a group of patients with NE tumors (n = 14) and compared to a group of patients with colorectal adenocarcinomas… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2015
View 11 Excerpts

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine • 2005

Similar Papers

Loading similar papers…